Tamoxifen was found to decrease VEGF expression; however, breast cancer cells that have de novo resistance or acquired resistance towards tamoxifen treatment showed upregulated VEGF expression, and this has been demonstrated in MCF-7 cells previously [33–35]. Here, VEGFA is linked to breast carcinoma.